Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cencora (GB:0HF3)
LSE:0HF3
Holding GB:0HF3?
Track your performance easily
0HF3 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$191.43 - $251.33
Previous Close$249.53
Volume8.59K
Average Volume (3M)3.42K
Market Cap
$49.02B
Enterprise Value$50.58B
Total Cash (Recent Filing)$3.31B
Total Debt (Recent Filing)$4.73B
Price to Earnings (P/E)33.1
Beta0.21
Next Earnings
Jan 30, 2025EPS Estimate
$3.5Next Dividend Ex-Date
Nov 15, 2024Dividend Yield0.82%
Share Statistics
EPS (TTM)7.51
Shares Outstanding197,046,826
10 Day Avg. Volume3,586
30 Day Avg. Volume3,424
Standard Deviation0.06
R-Squared0.05
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)53.48
Price to Sales (P/S)0.17
Price to Cash Flow (P/CF)5.00
P/FCF Ratio5.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.18
Enterprise Value/Gross Profit5.65
Enterprise Value/Ebitda13.81
Forecast
1Y Price Target
$274.83Price Target Upside9.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Cencora News
Bulls Say, Bears Say
Bulls Say
Acquisition And Strategic ExpansionThe acquisition of Retina Consultants of America aligns with COR's strategy and is expected to be accretive to earnings per share within the first 12 months.
Financial Performance And GuidanceFY25 adjusted EPS guidance exceeds consensus estimates, highlighting strong financial performance and not including benefits from an upcoming acquisition.
Segment Growth And Market PositionExpectations of solid segment growth driven by continued business momentum, including from utilization trends, position COR favorably in the market.
Bears Say
Customer RelationshipsCencora’s relationship with its two largest customers, Walgreens and Cigna, are each evolving – which may act as an overhang.
Earnings OutlookExpected EPS growth is at the lower end of the company's long-term guidance due to COVID-related challenges and loss of a distribution contract.
Financial PerformanceNet Cash from Operations of $1B was down from the prior year $1.83B.
---
Options Prices
Currently, No data available
---
Ownership Overview
10.47% Insiders
26.79% Mutual Funds
13.17% Other Institutional Investors
26.70% Public Companies and
Individual Investors
0HF3 FAQ
What was Cencora’s price range in the past 12 months?
Cencora lowest share price was $191.43 and its highest was $251.33 in the past 12 months.
What is Cencora’s market cap?
Currently, no data Available
When is Cencora’s upcoming earnings report date?
Cencora’s upcoming earnings report date is Jan 30, 2025 which is in 77 days.
How were Cencora’s earnings last quarter?
Cencora released its earnings results on Nov 06, 2024. The company reported $3.34 earnings per share for the quarter, beating the consensus estimate of $3.226 by $0.114.
Is Cencora overvalued?
According to Wall Street analysts Cencora’s price is currently Undervalued.
Does Cencora pay dividends?
Cencora pays a Quarterly dividend of $0.55 which represents an annual dividend yield of 0.82%. See more information on Cencora dividends here
What is Cencora’s EPS estimate?
Cencora’s EPS estimate is $3.5.
How many shares outstanding does Cencora have?
Cencora has 197,046,830 shares outstanding.
What happened to Cencora’s price movement after its last earnings report?
Cencora reported an EPS of $3.34 in its last earnings report, beating expectations of $3.226. Following the earnings report the stock price went up 4.438%.
Which hedge fund is a major shareholder of Cencora?
Among the largest hedge funds holding Cencora’s share is Antipodes Partners Ltd. It holds Cencora’s shares valued at 110M.
---
Cencora Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$274.83 (9.85% Upside)
$274.83 (9.85% Upside)
Blogger Sentiment
Bullish
GB:0HF3 Sentiment 100%
Sector Average 73%
Sector Average 73%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.52%
12-Months-Change
Fundamentals
Return on Equity
230.62%
Trailing 12-Months
Asset Growth
7.26%
Trailing 12-Months
Company Description
Cencora
Cencora, Inc. engages provision of pharmaceutical products and business solutions that improve access
to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical
Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic
pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded
sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and
health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate
site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and
includes ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Chesterbrook, PA.
---
0HF3 Company Deck
---
0HF3 Earnings Call
Q4 2024
0:00 / 0:00
---
0HF3 Revenue Breakdown
87.62% Human Health
8.52% Alliance Healthcare
1.93% Other Healthcare Solutions
1.92% Animal Health
---
0HF3 Stock 12 Month Forecast
Average Price Target
$274.83
▲(9.85% Upside)
Technical Analysis
Best Analysts Covering 0HF3
1 Year
1 Year Success Rate
38/40 ratings generated profit
1 Year Average Return
+20.48%
reiterated a buy rating 9 days ago
Copying Eric Coldwell's trades and holding each position for 1 Year would result in 95.00% of your transactions generating a profit, with an average return of +20.48% per trade.
---